AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2005
Apr 28, 2005
30339_dirs_2005-04-28_afdf1658-e25d-4f21-967c-f34067f571ed.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2005-04-27
Reporting Person: JOHNSON L ROBERT (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2005-04-27 | Phantom Stock Unit | $0.0000 | A | 1000 | Acquired | Common Stock (1000.00) | Direct | |
| 2005-04-27 | Stock Option (Right to Buy) | $26.3700 | A | 3200 | Acquired | 2015-04-27 | Common Stock (3200.00) | Direct |
Footnotes
F1: Awards of phantom stock units are to be settled only in cash upon the reporting person's termination as a director.
F2: Reflects addtional Phantom Stock Units credited through dividend reinvestment based on most recent plan statement.
More from WEST PHARMACEUTICAL SERVICES INC
Board/Management Information
2026
Jun 1
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Earnings Release
2026
Apr 23
Major Shareholding Notification
2026
Mar 27